|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, Illinois 60612
ABSTRACT
Interleukin 11 receptor alpha (Il11ra) null mice are infertile due to defective decidualization and abnormal trophoblast invasion. We have previously shown in these mice that downregulation of decidual proteinase inhibitors plays a role in uncontrolled trophoblast invasion. However, the decidua is abnormally smaller in pseudopregnant Il11ra null mice, where trophoblast invasion is not a factor. Here, we examined whether defective decidualization is due to dysregulation of key molecules involved in decidual cell growth and differentiation. We found a dramatic downregulation of cyclin D3 in Il11ra null mice. We also found that IL11 robustly stimulates the expression of cyclin D3 in cell culture. CDK4 and CDK6, known partners of cyclin D3, are not affected. Immunolocalization studies show absence of cyclin D3 in the mesometrial site and absence of differentiated polyploid cells in the antimesometrial site of Il11ra null mice. We also examined the expression of cell differentiation factors CDKN1A (p21) and CDKN1B (p27), and found that in both in vivo and cell culture the expression of CDKN1A (p21) but not CDKN1B (p27) is under the control of IL11. Another clear target of IL11 in the decidua is BIRC5 (Survivin), whose expression is repressed in the decidua of Il11ra null mice and stimulated by IL11 in cell culture. Taken together, these results provide, at least in part, an explanation for the defective small decidua of mice lacking the Il11ra gene, and reveal for the first time that cyclin D3, CDKN1A (p21), and BIRC5 (Survivin) are targets of IL11 in the decidua.
CDKN1A, cyclin D3, deciduas, IL11, implantation
Implantation and development of the embryo require extensive reorganization of the different tissues forming the uterus. Rapid growth and differentiation of the endometrial stroma are the earliest and most striking events that take place in the uterine milieu. This leads to the formation of special cells, termed decidual cells, that differ greatly from the original endometrial stromal cells. In rodents, the attachment of the embryo to the antimesometrial uterine epithelium elicits a local and extensive response that results in the formation of the antimesometrial decidua. Decidualization then extends mesometrially to form the mesometrial decidua comprised of cells much smaller and less differentiated than the antimesometrial decidual cells. The mechanisms involved in the differential growth and transformation of endometrial cells located in different sites of the uterus are not completely understood; however, the involvement of hormones is well known. For decidualization to occur, the uterus must be primed with progesterone alone or progesterone and estradiol [1–3]. Decidualization can be also induced artificially by various stimuli, such as trauma or injection of oil into the lumen of the hormonally primed pseudopregnant uterus. Artificial decidualization shares many of the features of natural decidualization. While the local molecular mechanisms driving decidualization are still largely unknown, a number of decidual-derived factors have been identified as differentiation factors in this process. These include extracellular matrix remodeling factors, lipid mediators, and homeobox and C/EBPβ transcription factors as well as cytokine leukemia inhibitory factor (LIF) and interleukin 11 (IL11) [4, 5].
IL11 is a member of the IL6 family of cytokines that is active on a range of different types of cells. Its effects include stimulation of hematopoietic progenitors, anti-inflammatory actions, effects on bone remodeling, and induction of acute-phase protein secretion by the liver [6, 7]. The biological effects of IL11 are mediated by association of the ligand with both its receptors (IL11R) and the signal transducer, gp130 [8]. IL11 is not detected in cycling or in early pregnant mice uterus; however, after decidualization, this cytokine becomes expressed in decidual cells, and its expression peaks between Days 6 and 9 of pregnancy [9, 10]. Gene deletion studies have revealed a key role for this cytokine in the process of decidualization. Female mice with either a null mutation of the gene encoding Il11ra [9] or a hypomorphic Il11ra allele [10] were found to be infertile due to defective decidualization. The decidua of Il11ra null mice is much smaller than that of wild-type mice and does not support successful pregnancy, causing fetal death between Days 8 and 9 [9]. This suggests that IL11 plays a key role in decidual growth and/or differentiation. During differentiation, decidual cells, located principally in the antimesometrial region of the uterus, acquire polyploidization, a hallmark for this event. The decidual cell polyploidy is characterized by formation of large mononucleated or binucleated cells, a characteristic of nuclear endoreduplication, consisting of DNA with four, eight, and even higher multiples of the haploid complement [11–13]. It is believed that endoreduplicated cells exhibit an array of cell cycle activities that direct continuous DNA synthesis without cell division. It has been reported previously that coordinate expression of cyclin D3 with CDKN1A (p21) and CDK6 drives development of polyploidy during stromal cell decidualization [14, 15].
In this report, using both in vivo and cell culture approaches, we examined whether IL11 regulates the expression of key molecules involved in decidual cell growth and endoreplication. We also examined whether deletion of Il11ra causes dysregulation in the expression of any of these cell cycle-regulating factors.
ExTaq DNA polymerase, ExTaq buffer, and deoxyribonucleotide triphosphate (dNTP) were purchased from Takara Biomedicals (Shiga, Japan); medium M199 without Phenol red, reverse transcrptase kit, T4 kinase kit, TRizol reagent, and the nucleotides used as primers in the RT-PCR analysis were obtained from Invitrogen (Carlsbad, CA); Western blotting Luminol Reagent was obtained from Santa Cruz Biotechnology (Santa Cruz, CA); medium M199 with Phenol red, antibiotic-antimycotic solution, nonessential amino acids, sodium pyruvate, trypsin-EDTA, antibiotics, and antimycotics were purchased from Mediatech (Herndon, VA); and fetal bovine serum (FBS) was purchased from HyClone Laboratories (Logan, UT). Arachidonic acid, IL11, aprotinin, leupeptin, and phenylmethylsulfonyl fluoride were purchased from Sigma (St. Louis, MO); RIPA buffer was purchased from Boston Bioproducts (Ashland, MA).
Mice with germline transmission of the Il11ra null mutation were kept at 25°C with a 14L:10D cycle and were fed a commercial pelleted diet ad libitum. Heterozygous mutants in the C57BL/6 x 129/sv background were intercrossed to generate +/+, +/–, and –/– (null) mice, which were genotyped by Southern blot using tail DNA. Il11ra null and wild-type mice were mated with either vasectomized males or wild-type males to induce either pseudopregnancy or pregnancy. Decidualization was induced in pseudopregnant mice with intrauterine administration of oil on Day 4. The decidual tissues were collected on Days 7, 8, and 9. All experimental procedures were performed in accordance with the principles of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee.
The rat uterine stromal cells, UIII, established from adult, untreated uteri [16] were grown in M199 medium supplemented with FBS (10%), nonessential amino acids, and antibiotic-antimycotic solution. They were incubated in a humidified atmosphere of 5% CO2 at 37°C. Culture media were replaced every 48 h and cells harvested at 70%–90% confluence. Cells were treated with various concentrations of IL11 in medium M199 supplemented with 1% charcoal dextran-stripped FBS containing arachidonic acid (30 µM), which is essential for the in vitro differentiation of UIII cells [17]. At the end of the treatment, cells were washed twice with ice-cold PBS and frozen at –80°C until RNA extraction.
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from the decidual tissue of mice using Trizol reagent (Life Technologies Inc., Gaithersburg, MD) according to the manufacturer's instructions. The RT and PCR reactions were conducted as previously described [18]. For the PCR reaction, the conditions were such that amplification of the product was in the exponential phase, and the assay was linear with respect to the amount of input cDNA. Reaction products were electrophoresed on 2% agarose gel. Gels were stained with Tris-Borate-EDTA (TBE) containing 0.5 µg/ml ethidium bromide and washed three times. The resulting gels were photographed using a UV transilluminator and a digital camera (Electrophoresis Documentation and Analysis System 120; Eastman Kodak Co., New Haven, CT).
Primers for RT-PCR are described as follows. For mice, cyclin D3 primers used were 5'-CGTGCAAAAGGAGATCAAGC-3' and 5'-AATCAAGGCCAGGAAGTCG-3'; Cdkn1a (p21) primers used were 5'-CGGTGGAACTTTGACTTCGT-3' and 5'-CAGGGCAGAGGAAGTACTGG-3'; Cdkn1b (p27) primers used were 5'-CAGAATCATAAGCCCCTGGA-3' and 5'-TCTGACGAGTCAGGCATTTG-3'; and Birc5 (Survivin) primers used were 5'-TACCTCAAGAACTACCGCATCG-3' and 5'-AAGGCTCAGCATTAGGCAGC-3'. For rat uterine cell line, Cdkn1a (p21) primers used were 5'-TGGACAGTGAGCAGTTGAGC-3' and 5'-ACACGCTCCCAGACGTAGTT-3'; and Cdkn1b (p27) primers used were 5'-AGGAGAGCTTGGATGTCAGC-3' and 5'-TCTGACGAGTCAGGCATTTG-3'.
Western blots were performed as described previously [19]. Briefly, 40 µg proteins were separated on SDS-PAGE gel and transferred to a nitrocellulose membrane. Western blotting was performed by blocking nonspecific binding with 5% dry milk in Tris-buffered saline buffer containing 1% Tween 20 for 1 h. Blots were then incubated with the primary antibody at a final dilution of 1:1000, cyclin D3 (Santa Cruz, sc-182; Santa Cruz Biotechnology), CDKN1A/p21 (Santa cruz, sc-397), CDK4 (Santa cruz, sc-601), CDK6 (Santa cruz, sc-7180), BIRC5/Survivin (Santa cruz, sc-10811), and CDKN1B/p27 (2552; Cell Signaling Technology), and overnight at 4°C on a rocking platform. After a series of washes, blots were incubated with a secondary antibody linked to horseradish peroxidase for 1 h. After extensive washing, blots were analyzed using an enhanced chemiluminescence detection system and exposed to x-ray film.
Paraffin-embedded sections were subjected to the avidin-biotin-peroxidase complex (ABC) method using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Briefly, formalin-fixed, paraffin embedded sections (5 µm) were deparaffinized, hydrated, and irradiated in a microwave oven for the antigen retrieval and then with 0.3% (w/v) hydrogen peroxidase for 30 min to block endogenous peroxidase activity. After washing in PBS, sections were treated with normal goat serum for 30 min to eliminate any nonspecific binding of conjugated secondary antibodies. Then, the slides were incubated overnight at 4°C with a polyclonal antibody to cyclin D3 (Santa Cruz Biotechnology) at a final dilution of 1:400. After rinsing with PBS, sections were incubated with a biotinylated second antibody for 30 min at room temperature, and then incubated for another 30 min with the ABC reagent. Finally, they were incubated with diaminobenzidine solution containing 0.03% (w/v) hydrogen peroxidase for 5 min. Sections were washed in PBS for 5 min three times between each step. Negative controls consisted of sections incubated with normal goat serum instead of primary antibody.
Data were examined by t-test, one-way ANOVA followed by the Tukey test using Prism software (GraphPad Software Inc., San Diego, CA). Values were considered statistically significant at P < 0.05.
Regulation of Cyclin D3 by IL11
We first examined whether there is any defect in the expression of cell cyclin D3 in decidualization in Il11ra null mice, since this cell cycle regulator was shown to be essential for decidual cell growth [14]. Either wild-type or Il11ra null mice were mated with vasectomized males to induce pseudopregnancy. On Day 4 of pseudopregnancy, decidualization was induced with intrauterine administration of oil. Decidual tissue was collected on Days 8 and 9, and cyclin D3 expression was examined by RT-PCR and Western blot analysis. Cyclin D3 expression was dramatically downregulated at both mRNA (Fig. 1A) and protein (Fig. 1B) levels in the decidua of Il11ra null mice, suggesting that cyclin D3 expression in the decidua depends on IL11 signaling.
|
To further examine whether IL11 indeed regulates cyclin D3 expression in decidual cells, we used a nontransformed rat uterine stromal cell line (UIII), which decidualizes in the presence of arachidonic acid. This cell line was previously characterized by our laboratory [20] and found to be responsive to IL11 [21]. As shown in Figure 1C, IL11 markedly stimulates the expression of cyclin D3 in cultured decidual cells.
Immunohistochemical analysis (Fig. 2, A and B) indicates that expression of cyclin D3 protein is almost absent from the mesometrial decidual cells of Il11ra null mice. This lack of expression correlates with severe defect in the normal growth of the mesometrial decidua, as reported previously [9], and as shown in Figure 2A. In contrast, cyclin D3 is localized in the antimesometrial decidual cells of both Il11ra–/– (Fig. 2D) and Il11ra+/+ (Fig. 2E) mice. Interestingly, however, large nuclei, characteristic of polyploidy of antimesometrial cells, are barely seen in Il11ra–/– mice.
|
Lack of Effect of IL11 on CDK4 and CDK6 Expression
We examined the expression of CDK4 and CDK6, the known partners of cyclin D3, in the Il11ra null mouse decidua. As shown in Figure 3, A and B, there are no differences in the expression of either CDK in the decidua of wild-type and Il11ra null mice. In addition, IL11 has no effect on the expression of either CDK4 or CDK6 in UIII cells at any doses used (Fig. 3, C and D).
|
Expression and Regulation of Cell Differentiation Factors CDKN1A (p21) and CDKN1B (p27)
Initiation of cell cycle arrest and cell differentiation involves the induction of endogenous CDK inhibitors (CDKN1A and CDKN1B), which bind to cyclin/CDK complexes to inhibit their activity [22, 23]. A role for CDKN1A (p21) in the development of polyploidy during stromal cell decidualization has been shown [12]. This led us to investigate whether dysregulation in CDKN1A (p21) and/or CDKN1B (p27) expression contributes to the decidual defect of Il11ra null mice. As shown in Figure 4, CDKN1A (p21) is dramatically reduced in the decidua of Il11ra null mice at both mRNA (Fig. 4A) and protein (Fig. 4B) levels compared with that in wild-type mice. Furthermore, IL11 treatment of UIII cells upregulates exquisitely Cdkn1a (p21) expression (Fig. 4C). In contrast to Cdkn1a (p21), Cdkn1b (p27) mRNA and protein expression is not effected at all by deletion of Il11ra in vivo (Fig. 5, A and B). IL11 treatment of UIII cells also has no detectable effect (Fig. 5C). These findings indicate that CDKN1A (p21) is clearly a target of IL11 and that decidual CDKN1A (p21) is highly sensitive to IL11 stimulation.
|
|
IL11 Effect on BIRC5 (Survivin) Expression
Because BIRC5 (Survivin), a protein shown to play an important role in cell survival, is stimulated by IL11 in other cell types [24, 25], we examined its expression in the Il11ra null mouse decidua and examined whether this protein is a target of IL11. We found Birc5 (Survivin) to be barely detectable in the Il11ra null mice (Fig. 6A). We also found that 50 and 100 ng/ml IL11 stimulates significantly BIRC5 (Survivin) expression in cell culture.
|
Uterine decidualization, characterized by stromal cell proliferation and differentiation with polyploidy, is critical for pregnancy in mice. Il11ra null mice are infertile due to defects in decidual formation. Growth and differentiation of endometrial stromal cells do take place in the uterus of Il11ra null mice after implantation, but the deciduas that form are much smaller than normal and are unable to limit trophoblast invasion [9, 10, 21]. We have previously shown that downregulation of decidual proteinase inhibitors, such as
2-macroglobulin and tissue inhibitor of metalloproteinases 3, could lead to uncontrolled trophoblast invasion and failure of functional placenta formation in these mice [21]. However, the finding that the decidua of Il11ra null mice is abnormally small not only in pregnant but also in pseudopregnant mice where trophoblast invasion is not a factor indicates that other defects intrinsic to decidual cells contribute to the infertility of these mice. In this report, we show that IL11 plays an important role in the expression of specific decidual proteins involved in growth, differentiation, and survival.
The best known regulators of mammalian cell proliferation are the D-type cyclins, which are considered to be key regulators of cell proliferation and transition of G1/S phase in the cell cycle [26–29]. These proteins mediate their action by binding to catalytic subunits of specific cyclin-dependent kinases [22, 27, 29]. A role for cyclin D3 in both growth and polyploidy of decidual cells was previously shown [12–15]. In this report, we found that IL11 stimulates cyclin D3 expression at both mRNA and protein levels in decidual cells. We also found a profound downregulation of this cell cycle protein in the decidua of Il11ra null mice. Cyclin D3 generally associates with CDK4 or CDK6 for cell proliferation. We found no change in the expression of either CDK in the Il11ra null mouse decidua. Nevertheless, the low expression of cyclin D3 indicates low complex formation between cyclin D3/CDKs 6 and 4 and decreased CDK activity. Interestingly, the defect in cyclin D3 is localized principally in the mesometrial decidual cells. This protein, normally expressed highly in Day 8 mesometrial decidual cells that are actively dividing at this stage [12], is absent from the mesometrial decidual cells of Il11ra null mice. This lack of expression correlates with and may provide an explanation for the severe defect in the normal growth of the mesometrial deciduas, as shown in this report and as previously reported [9, 10].
In contrast to its defective expression in the mesometrial decidua, cyclin D3 expression appears normal in the antimesometrial decidua of the Il11ra null mice. However, cell polyploidization is profoundly compromised, and the large nuclei specific to polyploid cells in the antimesometrial zone of wild-type mice are rarely observed in the Il11ra null decidua. This suggests a possible defect in the differentiation and polyploidization of stromal cells in the absence of IL11 signaling. This possibility is further strengthened by our findings that CDKNIA (p21) is a target of IL11 and is exquisitely upregulated by this cytokine in decidual cells. CDKNIA (p21) and CDKNIB (p27) are CDK inhibitors involved in cell cycle arrest and cell differentiation. They bind to cyclin/CDK complexes to inhibit their activity [22, 23]. CDKNIA (p21) was shown to be related to terminal differentiation of decidual cells in a region-specific manner, whereas functional association of cyclin D3 with CDKNIA (p21) and CDK6 has been implicated in the development of polyploidy during stromal cell decidualization [12, 14, 15]. Our finding that, similarly to cyclin D3, CDKNIA (p21) is barely detectable in the decidua of Il11ra null mice and is a sensitive target to IL11 provides a likely explanation for the lack of differentiation and polyploidization in absence of IL11 signaling.
A third decidual target of IL11 found in this investigation is BIRC5 (Survivin), which is normally expressed in human endometrium and decidua [30, 31] and is stimulated by IL11 in other cell types [24, 25]. BIRC5 (Survivin) is a cell survival gene discovered by Ambrosini et al. in 1997 [32] and cloned in the mouse in 1999 [33]. BIRC5 (Survivin) is proposed to function as a mitotic regulator and as cell death inhibitor during development and pathogenesis. As such, BIRC5 (Survivin) has attracted great interest in both basic and translational research. BIRC5 (Survivin) acts as a subunit of the chromosomal passenger complex and is essential for chromosome segregation and cytokinesis. Recent findings indicate that interaction of BIRC5 (Survivin) with several proteins, such as Crm1 [34, 35] and HBXIP [36], seems to be required for its cytoprotective activity. BIRC5 (Survivin) is expressed and regulated in normal tissues characterized by self-renewal and proliferation, such as the decidua. The signaling pathways that activate BIRC5 (Survivin) expression are not yet totally characterized. Activation of STAT3 was, however, shown to upregulate BIRC5 (Survivin) expression [25, 37–39]. Our recent finding that IL11 does activate Jak2 and STAT3 in decidual cells [21] suggests strongly that IL11 stimulation of BIRC5 (Survivin) may involve this pathway. Interestingly, repression of cyclin D3 expression was reported to reduce BIRC5 (Survivin) levels profoundly [40]. It is therefore possible that the very low levels of BIRC5 (Survivin) in Il11ra null mice are due to lack of IL11 signaling and the low cyclin D3 expression.
Taken together, results of this investigation provide one explanation for the defect in the normal formation of the decidua and infertility of the Il11ra null mice and demonstrate for the first time that cyclin D3, CDKN1A (p21), and BIRC5 (Survivin) are downstream targets of IL11. In the absence of Il11ra, IL11 becomes unable to stimulate these proteins, which appears to be crucial for the normal growth, differentiation, and survival of the decidua and for maintenance of normal pregnancy.
ACKNOWLEDGMENTS
We are grateful to Dr. L. Robb (The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia) for providing us with Il11ra null mice.
FOOTNOTES
3These authors contributed equally to this work. ![]()
4Current address: Departments of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536. ![]()
1Supported by National Institutes of Health grants HD12356, U54 HD40093, and HD 11119. ![]()
Correspondence: 2Geula Gibori, Department of Physiology and Biophysics (M/C 901), University of Illinois at Chicago, 835 South Wolcott Ave., Chicago, IL 60612. FAX: 312 413 0159; e-mail: ggibori{at}uic.edu
Received: 5 June 2007.
First decision: 29 June 2007.
Accepted: 14 September 2007.
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |